Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders
- Conditions
- Mood Disorders
- Interventions
- Device: TMS
- Registration Number
- NCT02917499
- Lead Sponsor
- Sveti Ivan Psychiatric Hospital
- Brief Summary
The goal of this study is to examine the efficacy and safety of transcranial magnetic stimulation (TMS) and deep TMS (dTMS) for treatment of different psychiatric and neurological disorders. Subjects will be randomized into two groups: experimental (treated with pharmacotherapy and TMS) and control group (treated only with pharmacotherapy). They and their clinicians will complete a battery of instruments that measure relevant symptoms, global functioning and quality of life. The first measurement will be done after the inclusion and before treatment. The second measurement will be made immediately after the end of treatment (after 4 weeks). The other measurements (follow-up) will be made after 3 and 6 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 228
- diagnosed psychiatric or neurological disorder, duration of disorder for at least 5 years, inpatients or outpatients treated in Psychiatric hospital Sveti Ivan
- suicidality, psychosis, alcohol addiction, unable to complete the questionnaires
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TMS TMS The experimental group will be treated with transcranial magnetic stimulation for 4 weeks.
- Primary Outcome Measures
Name Time Method the proportion of patients who experienced complete remission of the disease up to six months Measurement points: immediately after the end of treatment, and follow-up after 3 and 6 months.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
PB Sveti Ivan
ðŸ‡ðŸ‡·Zagreb, Croatia